Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Cold Flu and Allergy Remedies in the United States Mintel, Oct 2007, Pages: 95   Description     Table of Contents     Companies Mentioned        Enquire before Buying    Send to a Friend   The U.S. cold, flu, and allergy remedies market relies heavily on new product innovation. Greatly influenced by seasonal rhythms and the rising cost of healthcare, the market changes dramatically with changes in vaccines and in the prescription market. This report will help you understand: - The huge impact of prescription to over-the-counter switches in tablets, including Claritin and the impending migration of Zyrtec. - The effect of the 2006 Stop Meth Act, which moved pseudoephedrine products behind the counter, inconveniencing customers and highlighting potential dangers of over-the-counter remedies. - Activity from the seven leading remedy manufacturers, and the effect of the Johnson & Johnson/Pfizer merger on the supply chain and advertising/promotional strategies. - The retail landscape, dominated by the drug channel, and the attempts of food and mass channels to adopt similar pharmaceutical services. - Close inspection of consumer behavior regarding remedies and the conditions they treat, yielding ideas about how manufacturers can increase usage and penetration. Moreover, this report features in-depth analysis of the future of the market, including potential of and competition from alternative remedies; the impact of voluntary withdrawal of infants’ remedies; and the threat of FDA findings which may limit or stop sales of children’s remedies. Not covered in this report are lozenges, medicated sweets, and products for the relief of coughs and sore throats. Customers who bought this item also bought OTC Pediatrics in the United States 2008 Cough and Throat Remedies in the United States 2008 OTC Paediatrics in the US 2006 Cold and Flu Remedies in the UK 2006 Cough, Cold and Allergy (Hay Fever) Remedies in Japan Cough, Cold and Allergy (Hay Fever) Remedies in France Cough, Cold and Allergy (Hay Fever) Remedies in Denmark Cough, Cold and Allergy (Hay Fever) Remedies in the United Kingdom Medicated Skincare in the United States 2007 Cough, Cold and Allergy (Hay Fever) Remedies in China Cough, Cold and Allergy (Hay Fever) Remedies In Hong Kong, China OTC Analgesics in the United States

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster